Form 8-K - Current report:
SEC Accession No. 0001493152-22-021259
Filing Date
2022-08-04
Accepted
2022-08-04 09:30:23
Documents
13
Period of Report
2022-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36696
2 ex99-1.htm EX-99.1 11877
  Complete submission text file 0001493152-22-021259.txt   225465

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pcsa-20220804.xsd EX-101.SCH 3004
4 XBRL LABEL FILE pcsa-20220804_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pcsa-20220804_pre.xml EX-101.PRE 22389
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3618
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 221135122
SIC: 2834 Pharmaceutical Preparations